Acute kidney injury following HCT: incidence, risk factors and outcome
Acute kidney injury (AKI) is a common complication in haematopoietic cell transplantation (HCT) patients and it adversely affects outcome. Herein, we provide a comprehensive and contemporary discussion of the incidence, risk factors and outcome of AKI in patients undergoing HCT, focusing on the diff...
Gespeichert in:
| Veröffentlicht in: | Bone marrow transplantation (Basingstoke) 2011-11, Vol.46 (11), p.1399-1408 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1408 |
|---|---|
| container_issue | 11 |
| container_start_page | 1399 |
| container_title | Bone marrow transplantation (Basingstoke) |
| container_volume | 46 |
| creator | Lopes, J A Jorge, S |
| description | Acute kidney injury (AKI) is a common complication in haematopoietic cell transplantation (HCT) patients and it adversely affects outcome. Herein, we provide a comprehensive and contemporary discussion of the incidence, risk factors and outcome of AKI in patients undergoing HCT, focusing on the differences between the myeloablative and nonmyeloablative regimens. |
| doi_str_mv | 10.1038/bmt.2011.46 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_968176950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A273079478</galeid><sourcerecordid>A273079478</sourcerecordid><originalsourceid>FETCH-LOGICAL-c643t-aefd7184696d30c364b17e652824f1d4e6122ea78e582e926118a0f09b37bee63</originalsourceid><addsrcrecordid>eNqF0ktvEzEUBtARAtFQWLFHIxCwoBP8Gj_YRRGlSJXYlLXleK5TpzN2sWeE8u9xSCAUFSEvLNnn-nH1VdVzjOYYUfl-NYxzgjCeM_6gmmEmeNNS3j6sZohw2VDK1Un1JOcNQpgx1D6uTgimknJJZtX5wk4j1De-C7CtfdhMaVu72Pfxuw_r-mJ59aGsWt9BsHBWJ59vamfsGFOuTejqOI02DvC0euRMn-HZYT6tvp5_vFpeNJdfPn1eLi4byxkdGwOuE1gyrnhHkaWcrbAA3hJJmMMdA44JASMktJKAIhxjaZBDakXFCoDT0-rt_tzbFL9NkEc9-Gyh702AOGWtuMSCqxb9XyKKWUuIKvLlX3ITpxTKNwoqHWRS4YJe_QsRzghBlDB-VGvTg_bBxTEZu7tYL4igSCgmZFHze1QZHQzexgDOl_U7BW_-KLgG04_XOfbT6GPId-G7PbQp5pzA6dvkB5O2GiO9C4suYdG7sOifr31x-NO0GqD7bX-lo4DXB2CyNb1LpiQhHx0TCnHGijvbu1y2whrSsTn33fsDNz7PwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2642203246</pqid></control><display><type>article</type><title>Acute kidney injury following HCT: incidence, risk factors and outcome</title><source>Nature_系列刊</source><source>MEDLINE</source><source>Springer Journals</source><source>EZB*</source><creator>Lopes, J A ; Jorge, S</creator><creatorcontrib>Lopes, J A ; Jorge, S</creatorcontrib><description>Acute kidney injury (AKI) is a common complication in haematopoietic cell transplantation (HCT) patients and it adversely affects outcome. Herein, we provide a comprehensive and contemporary discussion of the incidence, risk factors and outcome of AKI in patients undergoing HCT, focusing on the differences between the myeloablative and nonmyeloablative regimens.</description><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/bmt.2011.46</identifier><identifier>PMID: 21383682</identifier><identifier>CODEN: BMTRE9</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/1585/4 ; 692/700/565/545/576/1955 ; Acute Kidney Injury - epidemiology ; Acute Kidney Injury - etiology ; Acute Kidney Injury - mortality ; Acute renal failure ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Bone marrow ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Cell Biology ; Cyclosporine - adverse effects ; Distribution ; Graft vs Host Disease - complications ; Hematology ; Hematopoietic Stem Cell Transplantation - adverse effects ; Hematopoietic stem cells ; Hepatic Veno-Occlusive Disease - complications ; Humans ; Incidence ; Internal Medicine ; Kidneys ; Medical sciences ; Medicine ; Medicine & Public Health ; Myeloablative Agonists - adverse effects ; Nephrology. Urinary tract diseases ; Patient outcomes ; Public Health ; review ; Risk analysis ; Risk Factors ; Stem cell transplantation ; Stem Cells ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Transplantation ; Transplantation Conditioning - adverse effects ; Treatment Outcome ; Urinary system involvement in other diseases. Miscellaneous</subject><ispartof>Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1399-1408</ispartof><rights>Macmillan Publishers Limited 2011</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2011 Nature Publishing Group</rights><rights>Macmillan Publishers Limited 2011.</rights><rights>Copyright Nature Publishing Group Nov 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c643t-aefd7184696d30c364b17e652824f1d4e6122ea78e582e926118a0f09b37bee63</citedby><cites>FETCH-LOGICAL-c643t-aefd7184696d30c364b17e652824f1d4e6122ea78e582e926118a0f09b37bee63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/bmt.2011.46$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/bmt.2011.46$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24790644$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21383682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lopes, J A</creatorcontrib><creatorcontrib>Jorge, S</creatorcontrib><title>Acute kidney injury following HCT: incidence, risk factors and outcome</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><addtitle>Bone Marrow Transplant</addtitle><description>Acute kidney injury (AKI) is a common complication in haematopoietic cell transplantation (HCT) patients and it adversely affects outcome. Herein, we provide a comprehensive and contemporary discussion of the incidence, risk factors and outcome of AKI in patients undergoing HCT, focusing on the differences between the myeloablative and nonmyeloablative regimens.</description><subject>692/699/1585/4</subject><subject>692/700/565/545/576/1955</subject><subject>Acute Kidney Injury - epidemiology</subject><subject>Acute Kidney Injury - etiology</subject><subject>Acute Kidney Injury - mortality</subject><subject>Acute renal failure</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Cell Biology</subject><subject>Cyclosporine - adverse effects</subject><subject>Distribution</subject><subject>Graft vs Host Disease - complications</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation - adverse effects</subject><subject>Hematopoietic stem cells</subject><subject>Hepatic Veno-Occlusive Disease - complications</subject><subject>Humans</subject><subject>Incidence</subject><subject>Internal Medicine</subject><subject>Kidneys</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Myeloablative Agonists - adverse effects</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Patient outcomes</subject><subject>Public Health</subject><subject>review</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Stem cell transplantation</subject><subject>Stem Cells</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Transplantation</subject><subject>Transplantation Conditioning - adverse effects</subject><subject>Treatment Outcome</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqF0ktvEzEUBtARAtFQWLFHIxCwoBP8Gj_YRRGlSJXYlLXleK5TpzN2sWeE8u9xSCAUFSEvLNnn-nH1VdVzjOYYUfl-NYxzgjCeM_6gmmEmeNNS3j6sZohw2VDK1Un1JOcNQpgx1D6uTgimknJJZtX5wk4j1De-C7CtfdhMaVu72Pfxuw_r-mJ59aGsWt9BsHBWJ59vamfsGFOuTejqOI02DvC0euRMn-HZYT6tvp5_vFpeNJdfPn1eLi4byxkdGwOuE1gyrnhHkaWcrbAA3hJJmMMdA44JASMktJKAIhxjaZBDakXFCoDT0-rt_tzbFL9NkEc9-Gyh702AOGWtuMSCqxb9XyKKWUuIKvLlX3ITpxTKNwoqHWRS4YJe_QsRzghBlDB-VGvTg_bBxTEZu7tYL4igSCgmZFHze1QZHQzexgDOl_U7BW_-KLgG04_XOfbT6GPId-G7PbQp5pzA6dvkB5O2GiO9C4suYdG7sOifr31x-NO0GqD7bX-lo4DXB2CyNb1LpiQhHx0TCnHGijvbu1y2whrSsTn33fsDNz7PwQ</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Lopes, J A</creator><creator>Jorge, S</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20111101</creationdate><title>Acute kidney injury following HCT: incidence, risk factors and outcome</title><author>Lopes, J A ; Jorge, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c643t-aefd7184696d30c364b17e652824f1d4e6122ea78e582e926118a0f09b37bee63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>692/699/1585/4</topic><topic>692/700/565/545/576/1955</topic><topic>Acute Kidney Injury - epidemiology</topic><topic>Acute Kidney Injury - etiology</topic><topic>Acute Kidney Injury - mortality</topic><topic>Acute renal failure</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Cell Biology</topic><topic>Cyclosporine - adverse effects</topic><topic>Distribution</topic><topic>Graft vs Host Disease - complications</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation - adverse effects</topic><topic>Hematopoietic stem cells</topic><topic>Hepatic Veno-Occlusive Disease - complications</topic><topic>Humans</topic><topic>Incidence</topic><topic>Internal Medicine</topic><topic>Kidneys</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Myeloablative Agonists - adverse effects</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Patient outcomes</topic><topic>Public Health</topic><topic>review</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Stem cell transplantation</topic><topic>Stem Cells</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Transplantation</topic><topic>Transplantation Conditioning - adverse effects</topic><topic>Treatment Outcome</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lopes, J A</creatorcontrib><creatorcontrib>Jorge, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lopes, J A</au><au>Jorge, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute kidney injury following HCT: incidence, risk factors and outcome</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><stitle>Bone Marrow Transplant</stitle><addtitle>Bone Marrow Transplant</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>46</volume><issue>11</issue><spage>1399</spage><epage>1408</epage><pages>1399-1408</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><coden>BMTRE9</coden><abstract>Acute kidney injury (AKI) is a common complication in haematopoietic cell transplantation (HCT) patients and it adversely affects outcome. Herein, we provide a comprehensive and contemporary discussion of the incidence, risk factors and outcome of AKI in patients undergoing HCT, focusing on the differences between the myeloablative and nonmyeloablative regimens.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>21383682</pmid><doi>10.1038/bmt.2011.46</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0268-3369 |
| ispartof | Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1399-1408 |
| issn | 0268-3369 1476-5365 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_968176950 |
| source | Nature_系列刊; MEDLINE; Springer Journals; EZB* |
| subjects | 692/699/1585/4 692/700/565/545/576/1955 Acute Kidney Injury - epidemiology Acute Kidney Injury - etiology Acute Kidney Injury - mortality Acute renal failure Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Cell Biology Cyclosporine - adverse effects Distribution Graft vs Host Disease - complications Hematology Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic stem cells Hepatic Veno-Occlusive Disease - complications Humans Incidence Internal Medicine Kidneys Medical sciences Medicine Medicine & Public Health Myeloablative Agonists - adverse effects Nephrology. Urinary tract diseases Patient outcomes Public Health review Risk analysis Risk Factors Stem cell transplantation Stem Cells Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation Conditioning - adverse effects Treatment Outcome Urinary system involvement in other diseases. Miscellaneous |
| title | Acute kidney injury following HCT: incidence, risk factors and outcome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T06%3A47%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20kidney%20injury%20following%20HCT:%20incidence,%20risk%20factors%20and%20outcome&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Lopes,%20J%20A&rft.date=2011-11-01&rft.volume=46&rft.issue=11&rft.spage=1399&rft.epage=1408&rft.pages=1399-1408&rft.issn=0268-3369&rft.eissn=1476-5365&rft.coden=BMTRE9&rft_id=info:doi/10.1038/bmt.2011.46&rft_dat=%3Cgale_proqu%3EA273079478%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2642203246&rft_id=info:pmid/21383682&rft_galeid=A273079478&rfr_iscdi=true |